Atrial Fibrillation and Gastro-Oesophageal Reflux Disease - Controversies and Challenges

E-ISSN： 1873-4286|21|26|3829-3834

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.26, 2015-01, pp. : 3829-3834

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of pantoprazole in the treatment of gastro-oesophageal reflux disease

By Lehmann Frank Serge Beglinger Christoph

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 93-104

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for gastro-oesophageal reflux disease

By Wurm Peter De Caestecker John

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 457-471

Informa Healthcare

Access to resources Recommend Favorite

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease

By Thjodleifsson Bjarni

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 137-149

Informa Healthcare

Access to resources Recommend Favorite

Refractory Gastro-Oesophageal Reflux Disease: Diagnosis and Management

By Liu Julia J.

Drugs, Vol. 69, Iss. 14, 2009-10 ,pp. : 1935-1944

Adis International

Access to resources Recommend Favorite

The method of identifying patients with gastro-oesophageal reflux disease

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite